DA32 Life Science Tech Acquisition Corp.

DA32 Life Science Tech Acquisition Corp. (Nasdaq: DALS) is a blank-check company that registered its initial public offering via an S-1 filing with the Securities and Exchange Commission on July 2, 2021. Sponsored by DA32, the vehicle was formed to pursue a business combination with companies operating at the intersection of life science and technology, a sector that drew significant SPAC formation activity during the 2021 market cycle. The company listed on Nasdaq and targeted healthcare innovation and emerging technology as its primary acquisition focus. For complete filing timelines, sponsor profiles, and deal-status tracking on DALS and the broader SPAC universe, sign up for full data access on SpacDesk.